J. Russel Denton compensation by year
Caris Life Sciences Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $458,951 |
| Bonus | $263,897 |
| Stock awards | $2,085,741 |
| Option awards | $2,532,025 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $14,000 |
| Total | $5,354,614 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Caris Life Sciences, Inc. DEF 14A filed April 23, 2026, accession 0002019410-26-000032, and prior-year filings.
How this page was built: the Caris Life Sciences, Inc. filed document, accession 0002019410-26-000032. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 99,321 | $2,679,681 | — |
| RSU | 3,354 | $90,491 | — |
| Option | 51,000 | — | $18.60 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Caris Life Sciences, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Caris Life Sciences’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Dean Halbert | Founder, Chairman and Chief Executive Officer | $20,350,571 |
| David Spetzler | President | $11,583,227 |
| J. Russel Denton · this page | Senior Vice President, General Counsel and Secretary | $5,354,614 |
J. Russel Denton's compensation dossier, Caris Life Sciences
You have read J. Russel Denton's totals and holdings. The dossier adds each equity grant Caris Life Sciences disclosed for J. Russel Denton and Caris Life Sciences's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Caris Life Sciences compensation record
free company briefThis page is one person within Caris Life Sciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Caris Life Sciences's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Caris Life Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.